A
Akinlolu O. Ojo
Researcher at University of Michigan
Publications - 177
Citations - 26598
Akinlolu O. Ojo is an academic researcher from University of Michigan. The author has contributed to research in topics: Kidney disease & Transplantation. The author has an hindex of 64, co-authored 172 publications receiving 23629 citations. Previous affiliations of Akinlolu O. Ojo include National Institutes of Health.
Papers
More filters
Journal ArticleDOI
Comparison of Mortality in All Patients on Dialysis, Patients on Dialysis Awaiting Transplantation, and Recipients of a First Cadaveric Transplant
Robert A. Wolfe,Valarie B. Ashby,Edgar L. Milford,Akinlolu O. Ojo,Robert E. Ettenger,Lawrence Y. Agodoa,Philip J. Held,Friedrich K. Port +7 more
TL;DR: In this paper, the authors conducted a longitudinal study of mortality in 228,552 patients who were receiving long-term dialysis for end-stage renal disease, and 46,164 were placed on a waiting list for transplantation, 23,275 of whom received a first cadaveric transplant between 1991 and 1997.
Journal ArticleDOI
Chronic renal failure after transplantation of a nonrenal organ.
Akinlolu O. Ojo,Philip J. Held,Friedrich K. Port,Robert A. Wolfe,Alan B. Leichtman,Eric W. Young,J.A Arndorfer,Laura L. Christensen,Robert M. Merion +8 more
TL;DR: The five-year risk of chronic renal failure after transplantation of a nonrenal organ ranges from 7 to 21 percent, depending on the type of organ transplanted, and is associated with an increase by a factor of more than four in the risk of death.
Journal ArticleDOI
FGF23 induces left ventricular hypertrophy
Christian Faul,Ansel P. Amaral,Behzad N. Oskouei,Ming Chang Hu,Alexis Sloan,Tamara Isakova,Orlando M. Gutiérrez,Robier Aguillon-Prada,Joy Lincoln,Joshua M. Hare,Peter Mundel,Azorides R. Morales,Julia J. Scialla,Michael J. Fischer,Michael J. Fischer,Elsayed Z. Soliman,Jing Chen,Alan S. Go,Sylvia E. Rosas,Lisa Nessel,Raymond R. Townsend,Harold I. Feldman,Martin St. John Sutton,Akinlolu O. Ojo,Crystal A. Gadegbeku,Giovana Seno Di Marco,Stefan Reuter,Dominik Kentrup,Klaus Tiemann,Marcus Brand,Joseph A. Hill,Orson W. Moe,Makoto Kuro-o,John W. Kusek,Martin G. Keane,Myles Wolf +35 more
TL;DR: It is reported that elevated FGF23 levels are independently associated with LVH in a large, racially diverse CKD cohort and suggested that chronically elevated F GF23 levels contribute directly to high rates of LVH and mortality in individuals with CKD.
Journal ArticleDOI
Delayed graft function: risk factors and implications for renal allograft survival.
TL;DR: Delayed function and early rejection episodes exerted an additive adverse effect on allograft survival and the deleterious impact of delayed function is comparatively more severe than that of poor HLA matching.
Journal ArticleDOI
Fibroblast Growth Factor 23 and Risks of Mortality and End-Stage Renal Disease in Patients with Chronic Kidney Disease
Tamara Isakova,Huiliang Xie,Wei Yang,Dawei Xie,Amanda H. Anderson,Julia J. Scialla,Patricia Wahl,Orlando M. Gutiérrez,Susan Steigerwalt,Jiang He,Stanley Schwartz,Joan Lo,Akinlolu O. Ojo,James H. Sondheimer,Chi-yuan Hsu,James P. Lash,Mary B. Leonard,John W. Kusek,Harold I. Feldman,Myles Wolf +19 more
TL;DR: Elevated FGF-23 is an independent risk factor for end-stage renal disease in patients with relatively preserved kidney function and for mortality across the spectrum of chronic kidney disease.